Nurix Therapeutics Inc (NRIX) — Strategic Asset Allocation Index
Nurix Therapeutics Inc (NRIX) has a Strategic Asset Allocation Index of 0.0% as of November 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $526.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Nurix Therapeutics Inc Strategic Asset Allocation Index (2018–2024)
This chart shows how Nurix Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2018 to 2024. As of November 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $526.99 Million USD. Explore Nurix Therapeutics Inc (NRIX) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Nurix Therapeutics Inc (2018–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Nurix Therapeutics Inc from 2018 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NRIX market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $526.99 Million | ▼ -3.7 pp |
| 2023 | 3.7% | $7.42 Million | $- | $7.42 Million | $200.49 Million | ▼ -23.0 pp |
| 2022 | 26.7% | $81.04 Million | $17.16 Million | $63.88 Million | $303.70 Million | ▼ -20.8 pp |
| 2021 | 47.5% | $162.53 Million | $25.34 Million | $137.19 Million | $342.30 Million | ▲ +13.9 pp |
| 2020 | 33.6% | $97.56 Million | $6.67 Million | $90.89 Million | $290.27 Million | ▼ -5.4 pp |
| 2018 | 39.0% | $4.42 Million | $4.42 Million | $0.00 | $11.35 Million | — |